Deadline: December 1, 2014
Physician-scientists who are both clinically trained and expert researchers are essential to the successful translation of scientific discovery into more effective patient therapies. They have the unique capacity to blend their insights from treating patients and working in the laboratory in a way that enables and accelerates medical advances. However, the pipeline of physician-scientists is dwindling. The decline in this vital cadre of cancer researchers is occurring at a time when cancer research holds the greatest promise of improving survival and quality of life among cancer patients. A growing shortage of physician-scientists means that major laboratory research discoveries will progress to patient application ever more slowly. If the shortage continues unabated, some may not reach patient application at all, thus presenting a crisis in cancer.
In an effort to confront the crisis arising from a growing dearth of physician-scientists, Damon Runyon wishes to encourage more physicians to pursue research careers. To do so, the Foundation is establishing a pilot program designed to recruit outstanding U.S. Specialty Board-eligible physicians (MDs only) into cancer research careers by providing them with the opportunity for a protected research training experience under the mentorship of a highly qualified and gifted mentor after they have completed all of their clinical training.
The goals of the program are to: • transform these individuals into the highest quality physician-scientists, capable of conducting research that has the potential to transform the diagnosis, treatment and/or prevention of cancer • eliminate the financial disincentive to entering this career path.
The award will provide up to $460,000 over four years in financial support for the award recipient. In addition, the Foundation will retire up to $100,000 of any outstanding medical school debt owed.
The 2015 application deadline is Monday, December 1, 2014. Detailed information about the award, eligibility criteria, application guidelines and forms are available on the Foundation’s website, www.damonrunyon.org/for_scientists/more/physician_scientist_training_award_overview. If you have any questions, please call the Foundation at 212-455-0520
The Melanoma Research Alliance (MRA) announces its eighth annual Request for Proposals (RFP), soliciting translational research grant applications from scientists and clinicians around the world. The RFP calls for ideas that could lead to high impact near-term clinical application in melanoma detection, prevention, diagnosis, staging, or treatment. MRA will accept proposals for Established Investigator Awards, Pilot Awards, Young Investigator Awards, Academic-Industry Partnership Awards (Established Investigator and Teams), and Special Opportunity Awards. Several special opportunities are being made possible in collaboration with Amgen, Bristol-Myers Squibb (BMS), and the Society for Immunotherapy of Cancer (SITC). In addition, we are pleased to announce a Young Investigator award in Dermatology. During this cycle, MRA plans to award at least $7 million to new projects.
Melanoma is a leading cause of new cancers, and more effective options for patients and those at risk are urgently needed. Recent scientific and clinical advances have provided new hope, but much work remains to be done to end suffering and death from melanoma.
The RFP can be accessed below.
Please note the following key deadlines:
- November 11, 2014: Young Investigator Award (including Dermatology Young Investigators), Established Investigator Award (including BMS-MRA Established Investigators), and Pilot Award (including SITC-MRA Pilot Award) proposals are due.
- November 21, 2014: All Academic-Industry Partnership Award (for Established Investigators and Teams) and BMS-MRA Team Science Award proposals are due.
Full descriptions of each opportunity, including eligibility criteria and deadlines can be found in the RFP document below.
2014-2015 Request for Proposals
Questions: Laura Brockway-Lunardi, Ph.D., MRA Scientific Program Director, firstname.lastname@example.org
Application Due Date: September 30, 2014
The Nebraska Center on the Prevention of Obesity Diseases through Dietary Molecules (NPOD), funded by a Center for Biomedical Research Excellence grant from NIH, invites applications for its pilot grant competition. The primary objective of this pilot grant program is to stimulate research in the area of nutrient signaling and to enhance competitiveness in obtaining extramural support.
In this first call for proposals, priority will be given to proposals in two areas; we anticipate funding one project from each area:
- Area 1: Prevention of obesity-related diseases through dietary molecules. Proposals targeting this area are expected to focus on the prevention of obesity-related diseases through essential and non-essential dietary compounds. Proposals with a focus on biomarkers or treatment of disease will also be considered for funding through this mechanism.
- Area 2: Interactions between diet and microRNAs. Proposals targeting this area are expected to focus the effects of food-borne microRNAs on mammalian gene expression, or the effects of dietary compounds on the expression of genes coding for microRNAs. Proposals with a focus on phenotyping and the development of innovative research tools are encouraged.
The Nebraska Center on the Prevention of Obesity Diseases through Dietary Molecules (NPOD), funded by a Center for Biomedical Research Excellence grant from NIH, invites applications for its pilot grant competition. This competition is open to all UNL and UNMC faculty. The primary objective of this pilot grant program is to stimulate research in the area of nutrient signaling and to enhance competitiveness in obtaining extramural support. The first round of applications is due September 30, 2014, with an anticipated funding start date of December 1, 2014. The RFA and application form can be found at: http://nutrigenomics.unl.edu/npod-pilot-project-rfa-due-september-30-2014